BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17011566)

  • 21. High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults.
    Bilhorn KR; Luo Y; Lee BT; Wong ND
    Am J Cardiol; 2012 Nov; 110(10):1464-7. PubMed ID: 22858184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.
    Szapary PO; Bloedon LT; Samaha FF; Duffy D; Wolfe ML; Soffer D; Reilly MP; Chittams J; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):182-8. PubMed ID: 16284192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HDL cholesterol predicts coronary heart disease mortality in older persons.
    Corti MC; Guralnik JM; Salive ME; Harris T; Field TS; Wallace RB; Berkman LF; Seeman TE; Glynn RJ; Hennekens CH
    JAMA; 1995 Aug; 274(7):539-44. PubMed ID: 7629981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men.
    Skretteberg PT; Grundvold I; Kjeldsen SE; Erikssen JE; Sandvik L; Liestøl K; Erikssen G; Pedersen TR; Bodegard J
    Atherosclerosis; 2012 Jan; 220(1):250-6. PubMed ID: 22062589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men.
    Abdel-Maksoud MF; Eckel RH; Hamman RF; Hokanson JE
    J Clin Lipidol; 2012; 6(4):374-81. PubMed ID: 22836075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.
    Frystyk J; Berne C; Berglund L; Jensevik K; Flyvbjerg A; Zethelius B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):571-6. PubMed ID: 17119002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical biomarkers of high-density lipoprotein dysfunction among middle-aged Turks.
    Onat A; Can G; Murat S; Ciçek G; Örnek E; Yüksel H
    Anadolu Kardiyol Derg; 2012 Dec; 12(8):628-36. PubMed ID: 22968297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.
    Kappelle PJ; Dullaart RP; van Beek AP; Hillege HL; Wolffenbuttel BH
    Eur J Intern Med; 2012 Dec; 23(8):755-9. PubMed ID: 22819464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones.
    Onat A; Can G; Hergenç G; Küçükdurmaz Z; Uğur M; Yüksel H
    Cardiology; 2010; 115(4):297-306. PubMed ID: 20395681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
    Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
    Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
    Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
    Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting.
    Fukushima Y; Ohmura H; Mokuno H; Kajimoto K; Kasai T; Hirayama S; Miyauchi K; Miida T; Amano A; Daida H
    Atherosclerosis; 2012 Mar; 221(1):206-11. PubMed ID: 22245035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
    Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
    Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin and coronary heart disease: a prospective study and meta-analysis.
    Sattar N; Wannamethee G; Sarwar N; Tchernova J; Cherry L; Wallace AM; Danesh J; Whincup PH
    Circulation; 2006 Aug; 114(7):623-9. PubMed ID: 16894037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: a matched cohort study.
    Esteghamati A; Hafezi-Nejad N; Sheikhbahaei S; Heidari B; Zandieh A; Ebadi M; Nakhjavani M
    J Clin Lipidol; 2014; 8(3):279-86. PubMed ID: 24793349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
    Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
    Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Density Lipoprotein Subclasses and Noncardiovascular, Noncancer Chronic Inflammatory-Related Events Versus Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Duprez DA; Otvos J; Tracy RP; Feingold KR; Greenland P; Gross MD; Lima JA; Mackey RH; Neaton JD; Sanchez OA; Jacobs DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002295. PubMed ID: 26370448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.